Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$205.2 million.

  • Lifecore Biomedical, Inc. \De\'s Retained Earnings fell 2325.02% to -$205.2 million in Q2 2025 from the same period last year, while for May 2025 it was -$205.2 million, marking a year-over-year decrease of 2325.02%. This contributed to the annual value of -$205.2 million for FY2025, which is 2325.02% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical, Inc. \De\'s Retained Earnings is -$205.2 million, which was down 2325.02% from -$204.1 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Retained Earnings high stood at $39.0 million for Q1 2021, and its period low was -$205.2 million during Q2 2025.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Retained Earnings value was -$149.3 million (recorded in 2023), while the average stood at -$110.7 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Retained Earnings tumbled by 91566.82% in 2022, and later skyrocketed by 672.86% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Retained Earnings (Quarter) stood at -$10.1 million in 2021, then tumbled by 915.67% to -$102.7 million in 2022, then plummeted by 70.39% to -$175.1 million in 2023, then decreased by 9.36% to -$191.5 million in 2024, then dropped by 7.2% to -$205.2 million in 2025.
  • Its last three reported values are -$205.2 million in Q2 2025, -$204.1 million for Q1 2025, and -$191.5 million during Q4 2024.